Unlabelled: Contrast medium-induced nephropathy (CIN) is regarded as one of the most important complications after intravascular administration of radiographic contrast media and the third most common cause of hospital-acquired acute kidney injury. Contrast-induced nephropathy may develop in up to10% of patient with normal renal function but may be as high 25% in patient with risk factors.

Methods: A total of 192 medical records were obtained, in which 55 patient were eligible by our inclusion and exclusion criteria.

Results: A total four cases of CIN (7%) was identified and all were considered high-risk patients. In the patients that developed CIN only 50% received preventive IV hydration therapy in accordance to guidelines of the Contrast-Induced Nephropathy Consensus Panel. In 51 cases CIN was absent (93%). In the absent CIN group 22 were considered high-risk patients (43%) and 29 patients were low risk (57%). In the high-risk group with absent CIN, 77% received preventive IV hydration.

Conclusion: Study didn't show diabetes as a direct contributory factor for CIN development, but glycemia was not properly stratified. Screening and preventive strategies were not diligently complied in our institution, so there is a great need to incorporate a protocol in our institution in accordance to published guidelines.

Download full-text PDF

Source

Publication Analysis

Top Keywords

contrast-induced nephropathy
8
cases cin
8
considered high-risk
8
high-risk patients
8
received preventive
8
absent cin
8
cin
7
nephropathy
4
nephropathy induced
4
induced contrast
4

Similar Publications

This meta-analysis investigates the potential of allopurinol to prevent contrast-induced nephropathy (CIN), a common and serious complication of percutaneous coronary intervention (PCI). CIN is particularly prevalent among high-risk populations, including patients with chronic kidney disease (CKD) or acute coronary syndrome (ACS), where the administration of contrast agents can exacerbate renal injury. Allopurinol, a xanthine oxidase inhibitor, is known for its dual action in reducing oxidative stress and uric acid production, positioning it as a promising therapeutic candidate to mitigate CIN.

View Article and Find Full Text PDF

Contrast-induced nephropathy (CIN) poses a significant risk following primary percutaneous coronary intervention (pPCI) in patients with ST-Elevation Myocardial Infarction (STEMI). Magnesium (Mg²⁺) deficiency has been associated with renal dysfunction and cardiovascular diseases, yet its role in CIN development remains unclear. This study represents the first investigation exploring the relationship between Mg²⁺ levels and CIN in this context.

View Article and Find Full Text PDF

Patients with chronic kidney disease (CKD) are at increased risk of acute kidney injury following exposure to contrast media. We evaluated the effect of melatonin, a potent antioxidant, as a protective strategy against contrast-induced acute kidney injury (CI-AKI), with a focus on molecular mechanisms. We randomized patients with an eGFR < 60 mL/min/1.

View Article and Find Full Text PDF

Objective: The triglyceride glucose (TyG) index is a biomarker of insulin resistance and is associated with an increased risk of cardiovascular events. Contrast-induced nephropathy (CIN) is an important complication that causes poor outcomes in patients undergoing percutaneous coronary intervention (PCI). In this study, we aimed to investigate the relationship between the TyG index and CIN and mortality in patients who underwent PCI due to chronic total coronary occlusion (CTO).

View Article and Find Full Text PDF

Contrast-induced acute kidney injury is a common complication marked by reduced kidney function within 48  hours of contrast administration. The aim of this study was to evaluate renal function, anatomy, and molecular changes at 24  hours, 48  hours, and 72  hours post-iodinated contrast media (ICM) administration. This true-experimental study used a post-test-only control group design.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!